trial · primary record
Carfilzomib
Kidney Transplant Rejection
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 25 |
| Primary completion | 2027-06-30 |
| Primary endpoint | Proportion of subjects who do not meet a stopping rule for safety and remain free of all of the following: Grade 3 or higher infusion reaction, Grade 3 or higher infections, and any malignancy excluding localized non-melanomatous skin cancer. |
| Registry ID | NCT06918990 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:28:11.288Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06918990
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.